Clinic
Gorman Medical LLC
Gorman Medical LLC was paid $5.08M by Medicaid between Jan 2018 and Dec 2024, across 58 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 48% of everything it billed.
33Billing provider infoGORMAN MEDICAL LLC
COLORADO SPRINGS, CO 80920
COLORADO SPRINGS, CO 80920
33aNPI1588089718assigned 02/25/2014
33bProvider typePain Clinic/Center
28Total paid$5.08M
24GClaims138,935
24DCodes billed58
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pain Clinic/Center providers in Colorado
Rank by total paid#1 of 5
Median peer was paid$931K
This provider vs. median5.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 27,989 | $853K | |
| 2019 | 23,408 | $690K | |
| 2020 | 16,573 | $592K | |
| 2021 | 19,039 | $730K | |
| 2022 | 16,849 | $675K | |
| 2023 | 18,707 | $768K | |
| 2024incomplete | 16,370 | $768K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 48% | 33,206 | 27,774 | $2.46M |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 10% | 5,068 | 4,416 | $512K |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | 5.5% | 10,722 | 10,200 | $279K |
| 80305 | 3.6% | 18,719 | 16,541 | $182K | |
| 99408 | 3.3% | 9,134 | 8,754 | $167K | |
| 94010 | 3.1% | 6,522 | 5,831 | $157K | |
| 27096 | 2.9% | 1,458 | 1,249 | $146K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 2.8% | 4,802 | 4,354 | $143K |
| 96127 | 2.7% | 13,643 | 12,873 | $138K | |
| 99205 | Prolong outpt/office vis | 2.1% | 670 | 637 | $107K |
| 64493 | 1.8% | 1,642 | 1,420 | $89K | |
| 99443 | 1.5% | 863 | 780 | $78K |
46 more codes
| 76942 | 1.3% | 1,098 | $66K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.2% | 4,196 | $61K |
| 64495 | 1.1% | 1,559 | $56K | |
| 64494 | 1.0% | 1,616 | $53K | |
| 99406 | <1% | 3,943 | $36K | |
| 62322 | <1% | 1,624 | $35K | |
| 20553 | <1% | 1,589 | $33K | |
| 64490 | <1% | 453 | $30K | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 1,602 | $28K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 221 | $26K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 441 | $24K |
| 99152 | <1% | 1,111 | $21K | |
| 98928 | <1% | 635 | $20K | |
| 20611 | <1% | 932 | $19K | |
| 64492 | <1% | 417 | $17K | |
| 64491 | <1% | 485 | $17K | |
| 62320 | <1% | 456 | $11K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,320 | $10K |
| 99153 | Mod sedat endo service >5yrs | <1% | 463 | $9K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 645 | $9K |
| 81007 | <1% | 325 | $9K | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 503 | $5K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 218 | $4K |
| 99354 | <1% | 82 | $3K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,240 | $3K |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 2,486 | $3K |
| 90686 | <1% | 175 | $3K | |
| 90674 | <1% | 81 | $2K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 25 | $1K |
| 99385 | <1% | 13 | $1K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 404 | $841.53 |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 22 | $701.80 |
| H0049 | Alcohol and/or drug screening | <1% | 104 | $622.80 |
| 99402 | <1% | 12 | $607.53 | |
| 64483 | <1% | 14 | $527.80 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 14 | $481.97 |
| 96103 | <1% | 249 | $400.34 | |
| 64405 | <1% | 60 | $362.39 | |
| 81025 | <1% | 43 | $327.18 | |
| 64484 | <1% | 26 | $251.07 | |
| 20606 | <1% | 16 | $219.42 | |
| 64450 | <1% | 29 | $89.30 | |
| 99173 | <1% | 16 | $29.11 | |
| G9902 | Patient screened for tobacco use and identified as a tobacco user | 0% | 151 | $0.00 |
| J1010 | Injection, methylprednisolone acetate, 1 mg | 0% | 165 | $0.00 |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | 0% | 207 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGORMAN, FRANCES (OWNER / PROVIDER)